医学
热烧蚀
肺
烧蚀
放射科
核医学
导管消融
射频消融
放射外科
细胞
作者
Shahar Adar,Alexandra Ádám,Tamara Balogh,Mátyás Rédei,Karen Krisztina Fazekas,Mátyás Paczkó,Nina Galdzytska,Marie Anne Engh,András Bibok,Gábor Zoltán Duray,Péter Hegyi,Dénes B. Horváthy
出处
期刊:Lung Cancer
[Elsevier BV]
日期:2026-05-22
卷期号:217: 109467-109467
标识
DOI:10.1016/j.lungcan.2026.109467
摘要
INTRODUCTION: For patients with early-stage non-small cell lung cancer (NSCLC) who are unable to tolerate lobectomy, alternative locoregional treatments, including sublobar resection (SLR), stereotactic body radiation therapy (SBRT), or image-guided thermal ablation (IGTA) are available, yet their relative risks and benefits remain uncertain. This systematic review and meta-analysis aims to synthesize existing evidence and compare the survival outcomes of these modalities in early-stage NSCLC. METHODS: A systematic search was conducted through MEDLINE (PubMed), Embase, and CENTRAL on April 20, 2026. Comparative analyses were restricted to propensity score-matched (PSM) studies reporting hazard ratios (HRs) for overall survival (OS) and cancer-specific survival (CSS) in pathologically confirmed early-stage NSCLC. Single-arm pooled survival analyses were performed using reconstructed individual patient data to estimate time-to-event outcomes. Risk of bias was assessed using ROBINS-I for comparative analysis and the JBI checklist for single-arm analyses. RESULTS: Seven PSM studies comparing SBRT and SLR were included in the comparative analysis. SLR was associated with improved OS compared with SBRT (HR 1.51; 95% CI: 1.18-1.93), while CSS did not differ significantly (HR 1.08; 95% CI: 0.48-2.45). Sixteen studies were included in the single-arm analyses. Pooled 3-year OS estimates were 80% (95% CI: 75-86%) for SLR, 64% (95% CI: 56-73%) for SBRT, and 64% (95% CI: 48-86%) for IGTA. Corresponding pooled 3-year CSS estimates were 88% (95% CI: 84-92%), 84% (95% CI: 82-87%), and 76% (95% CI: 50-100%), respectively. CONCLUSIONS: SLR was associated with improved OS, although CSS did not differ significantly between the modalities. SBRT and IGTA represent acceptable alternatives in patients unsuitable for surgery. Treatment selection should be individualized through multidisciplinary assessment.
科研通智能强力驱动
Strongly Powered by AbleSci AI